103 related articles for article (PubMed ID: 7886102)
1. Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal.
King GR; Joyner C; Ellinwood EH
Pharmacol Biochem Behav; 1994 Dec; 49(4):883-9. PubMed ID: 7886102
[TBL] [Abstract][Full Text] [Related]
2. Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal.
King GR; Joyner C; Ellinwood EH
Pharmacol Biochem Behav; 1994 Mar; 47(3):451-7. PubMed ID: 8208762
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.
King GR; Xiong Z; Ellinwood EH
Psychopharmacology (Berl); 1998 Feb; 135(3):263-9. PubMed ID: 9498729
[TBL] [Abstract][Full Text] [Related]
4. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine.
King GR; Xiong Z; Ellinwood EH
Psychopharmacology (Berl); 1997 Mar; 130(2):159-65. PubMed ID: 9106914
[TBL] [Abstract][Full Text] [Related]
5. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
King GR; Joyner CM; Ellinwood EH
Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
[TBL] [Abstract][Full Text] [Related]
6. Intermittent and continuous cocaine administration: residual behavioral states during withdrawal.
King GR; Joyner C; Lee T; Kuhn C; Ellinwood EH
Pharmacol Biochem Behav; 1992 Sep; 43(1):243-8. PubMed ID: 1409810
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal from continuous or intermittent cocaine: behavioral responsivity to 5-HT1 receptor agonists.
King GR; Joyner CM; Ellinwood EH
Pharmacol Biochem Behav; 1993 Jul; 45(3):577-87. PubMed ID: 8332619
[TBL] [Abstract][Full Text] [Related]
8. Dopamine efflux during withdrawal from continuous or intermittent cocaine.
King GR; Kuhn C; Ellinwood EH
Psychopharmacology (Berl); 1993; 111(2):179-84. PubMed ID: 7870949
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity to the locomotor depressant effect of a dopamine receptor antagonist during cocaine withdrawal in the rat.
Baldo BA; Markou A; Koob GF
Psychopharmacology (Berl); 1999 Jan; 141(2):135-44. PubMed ID: 9952037
[TBL] [Abstract][Full Text] [Related]
10. The effects of continuous cocaine dose, treatment, and withdrawal duration on the induction of behavioral tolerance and dopamine autoreceptor function.
King GR; Hillburn C; Pinto G; Konen J
Pharmacol Biochem Behav; 2004 Jun; 78(2):293-300. PubMed ID: 15219770
[TBL] [Abstract][Full Text] [Related]
11. The effects of continuous 5-HT(3) receptor antagonist administration on the subsequent behavioral response to cocaine.
King GR; Pinto G; Konen J; Castro G; Tran S; Hilburn C
Eur J Pharmacol; 2002 Aug; 449(3):253-9. PubMed ID: 12167467
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences.
Davidson C; Lee TH; Ellinwood EH
Neurochem Int; 2005 Feb; 46(3):189-203. PubMed ID: 15670635
[TBL] [Abstract][Full Text] [Related]
13. Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration.
Davidson C; Lee TH; Xiong Z; Ellinwood EH
Neuropsychopharmacology; 2002 Oct; 27(4):542-53. PubMed ID: 12377391
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
King GR; Ellinwood EH; Silvia C; Joyner CM; Xue Z; Caron MG; Lee TH
J Pharmacol Exp Ther; 1994 May; 269(2):743-9. PubMed ID: 8182540
[TBL] [Abstract][Full Text] [Related]
15. Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats.
Rudoy CA; Van Bockstaele EJ
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1119-29. PubMed ID: 17513029
[TBL] [Abstract][Full Text] [Related]
16. The effects of continuous cocaine duration on the induction of behavioral tolerance and dopamine autoreceptor function.
King GR; Pinto G; Konen J; Hillburn C; Tran S; Love W; Cayse R; Castro G
Eur J Pharmacol; 2002 Jun; 446(1-3):111-8. PubMed ID: 12098592
[TBL] [Abstract][Full Text] [Related]
17. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist.
King GR; Xiong Z; Douglass S; Ellinwood EH
Eur J Pharmacol; 2000 Apr; 394(1):97-101. PubMed ID: 10771040
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization.
Davidson C; Lazarus C; Xiong X; Lee TH; Ellinwood EH
Eur J Pharmacol; 2002 Oct; 453(2-3):255-63. PubMed ID: 12398913
[TBL] [Abstract][Full Text] [Related]
19. Transient amelioration of the sensitization of cocaine-induced behaviors in rats by the induction of tolerance.
Dalia AD; Norman MK; Tabet MR; Schlueter KT; Tsibulsky VL; Norman AB
Brain Res; 1998 Jun; 797(1):29-34. PubMed ID: 9630493
[TBL] [Abstract][Full Text] [Related]
20. Withdrawal from continuous or intermittent cocaine: effects of NAN-190 on cocaine-induced locomotion.
King GR; Joyner C; Lee TH; Ellinwood EH
Pharmacol Biochem Behav; 1993 Feb; 44(2):253-62. PubMed ID: 8446658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]